Bernstein analyst Lee Hambright raised the firm’s price target on Stryker (SYK) to $450 from $440 and keeps an Outperform rating on the shares. The firm cites a strong Q1, as revenue of $5.9B grew 10.1% organic and beat consensus by 3%. Performance was healthy across regions and segments.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SYK:
- Stryker’s Strong Performance and Growth Potential Justify Buy Rating
- Stryker Corp’s Earnings Call Highlights Robust Growth
- Stryker price target raised to $456 from $405 at Roth Capital
- Stryker’s Strong Financial Performance and Strategic Positioning Justify Buy Rating
- Stryker’s Strong Financial Performance and Strategic Initiatives Drive Buy Rating
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue